Previous Article | Next Article ![]()
Journal of Virology, January 2003, p. 1368-1381, Vol. 77, No. 2
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.2.1368-1381.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Macromolecular Structure, Centro Nacional de Biotecnología, CSIC, Cantoblanco, 28049 Madrid,1 Universitat de Barcelona, Serveis Cientificotècnics, Unitats de Reconeixement Molecular in situ i Genòmica, 08028 Barcelona, Spain,2 Division of Virology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G11 5JR, United Kingdom3
Received 14 June 2002/ Accepted 10 October 2002
|
|
|---|
|
|
|---|
As part of our general interest in characterizing how viruses use endomembranes, we have being studying the morphogenetic pathway of bunyaviruses, another group that also uses the Golgi complex for their morphogenesis (11, 25). The family Bunyaviridae contains more than 300 named isolates classified into five genera: Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus, and Tospovirus. With the exception of hantaviruses, which are transmitted in excretions from persistently infected rodents, these viruses are transmitted by arthropod vectors. The prototype of the family, Bunyamwera virus, is the subject of this report. Several viruses of the family are considered "emerging viruses" that exhibit a worldwide distribution and cause severe disease in humans, including hemorrhagic fevers and encephalitis (e.g., Rift Valley fever, La Crosse, Hantaan, Oropouche, and Crimean-Congo hemorrhagic fever viruses) (9).
The extracellular infectious particles of bunyaviruses have been described as spherical structures of around 100 nm in diameter. These particles form after association of the three internal ribonucleoproteins (negative-sense viral RNA segments bound to the nucleocapsid N protein and the RNA polymerase, termed L protein) with intracellular membranes containing two envelope glycoproteins, G1 and G2 (34). As mentioned above, these interactions take place in Golgi membranes. Bunyamwera virus encodes two additional nonstructural proteins, named NSs and NSm, that are synthesized early in infection. NSs acts as a virulence factor by helping the virus to shut off host cell protein synthesis and to inhibit interferon production (6). In addition, NSs protein controls the activity of the viral polymerase (40). The role of NSm remains to be defined, but the fact that this protein accumulates in the Golgi complex suggests a potential role in virus assembly (26). The reasons for the unusual assembly location in Golgi are not understood, but it is proposed that a Golgi retention signal in one of the viral glycoproteins directs assembly to Golgi membranes (19). Immunocytochemical studies and infections at 15°C showed that Uukuniemi virus, a phlebovirus, assembles both in the pre-Golgi intermediate compartment and in the Golgi stack (14). Some New World hantaviruses are rather different in that assembly occurs in the plasma membrane and spherical particles with rod-like protrusions instead of round-shaped virions are produced (10). Simultaneous assembly in the Golgi complex and plasma membrane has been described as a rare event for Rift Valley fever phlebovirus (1). There is no characterization of the potential cellular factors acting in replication or assembly or of how and where the replication complexes are built.
With the help of cryomicroscopy methods applied to infected cells, we have studied the morphogenesis of Bunyamwera virus in two different cell types and have found a unique assembly pathway and viral polymorphism. Nowadays it is possible to overcome the intrinsic difficulties in correct ultrastructural preservation of large structures such as cells during processing for cryomicroscopy (15). As a direct consequence of these technical advances, we are getting closer to native structures than ever before. In fact, cryomicroscopy represents a revolution in biology (3, 20). The use of high-preservation methods at the ultrastructural level and the study of the dynamic phase of assembly with drugs that block intracellular transport are providing totally new information on how different viruses interact with intracellular membranes to assemble new infectious particles (2, 31, 33). Our present study shows that the Golgi complex, and in particular the trans subcompartment, is the central organelle for the first structural maturation of bunyaviruses. As described for the unrelated coronaviruses, a functional trans-Golgi is necessary for maturation of viral immature precursors. A second structural transformation takes place during egress of the viral particles to the extracellular environment. In addition, a new virus-related structure of unknown function, but intimately connected with the early phase of infection, is built in the Golgi area. We finally show that the virus causes an early and spectacular fragmentation of endomembranes in Vero cells, in which, however, the virus presents a similar, Golgi-dependent, morphogenetic pathway.
|
|
|---|
The antiserum against the extracellular form of Bunyamwera virus, the anti-N polyclonal antiserum, and the monoclonal antibody against Bunyamwera G1 protein were described previously (17, 39, 40). The anti-giantin antiserum was kindly provided by M. Renz (Institute of Immunology and and Molecular Genetics, Karlsruhe, Germany), the G1/93 monoclonal antibody, specific for the ERGIC-53 protein, was a kind gift of H. P. Hauri (Biozentrum, University of Basel, Basel, Switzerland), and the anti-PDI antibody was obtained from Affinity Bioreagents, Inc. (Golden, Colo.). The anti-tubulin (T3526) and anti-vimentin (V9 monoclonal antibody) were obtained from Sigma. Secondary antibodies conjugated with rhodamine or fluorescein were supplied by Southern Biotechnology Associates, Inc. (Birmingham, Ala.). The lectin wheat germ agglutinin (WGA) conjugated with rhodamine was a product of Molecular Probes (Eugene, Oreg.). Phalloidin conjugated with rhodamine was a product of Sigma. Secondary antibodies conjugated with colloidal gold were supplied by BioCell International (Cardiff, United Kingdom).
Infections and treatments with drugs. Multiple-step growth curves of Bunyamwera virus were obtained with BHK-21 and Vero cells. Confluent monolayers were infected with Bunyamwera virus at a multiplicity of infection of 0.001 PFU per cell. The inoculum was removed after a 1-h incubation, and the cells were washed twice with DMEM and overlaid with fresh DMEM supplemented with 2% fetal calf serum. Cells were maintained at 32°C, and supernatants were collected at different times postinfection (p.i.). Virus yields (PFU per milliliter) were determined by titer determination on cell monolayers. For the studies of viral assembly, cell monolayers were infected at 37°C and 1 PFU/ml. At different times p.i., cells were processed for immunofluorescence or fixed for electron microscopy analysis. Some cultures were subjected to treatments with different drugs. Megalomicin (MGM), a Golgi-disrupting drug (5) kindly supplied by B. Alarcón (Centro de Biología Molecular "Severo Ochoa", Madrid, Spain), was added to noninfected or infected cell cultures at a final concentration of 25 or 50 µM and different times p.i. (1, 2, 3, and 4 h p.i.). For Bunyamwera-infected monolayers, MGM was added at 4 h p.i, the option that provided a reversible blockade. The treatment was maintained for 6 h. After removing MGM, some cultures were incubated for 2 h longer in either the presence or the absence of 100 µg of cycloheximide per ml. Supernatants of the cultures were then collected for virus titer determination, and cell monolayers were fixed and processed for immunofluorescence or transmission electron microscopy (TEM).
Fluorescence microscopy. Cell monolayers grown on coverslips were washed with phosphate-buffered saline (PBS) and subjected to different conditions of permeabilization, depending on the specific element to be detected. To detect the Bunyamwera virus N protein, tubulin, or vimentin, cells were permeabilized for 10 min with methanol at -20°C. A mixture of methanol: acetone (1:1) was used to permeabilize cells before incubation with the monoclonal antibody against Bunyamwera G1 glycoprotein or WGA conjugated with rhodamine. For localizing the Golgi protein giantin, the ERGIC-53 protein, or the endoplasmic reticulum marker protein disulfide isomerase, cells were treated with 3% paraformaldehyde for 20 min after being incubated with PBS containing 0.1% bovine serum albumin (BSA). Samples were then incubated with PBS containing 100 mM glycine and permeabilized with methanol (3 min at -20°C). Finally, for actin detection, cells were treated with 4% paraformaldehyde for 15 min, incubated with PBS containing 100 mM glycine, and permeabilized with 0.2% Triton X-100 for 10 min before incubation of the monolayers with 1 µM phalloidin-rhodamine. Dilutions (in PBS containing 0.1% BSA) for the different primary antibodies were as follows: 1:200 for anti-G1, anti-N, and anti-Bunyamwera virus; 1:50 for anti-giantin, anti-ERGIC-53, and anti-PDI; and 1:100 for anti-tubulin and anti-vimentin. After permeabilization and treatment with PBS containing 2% BSA, coverslips were incubated with the corresponding secondary antibodies diluted 1:600 in PBS containing 0.1% BSA, washed with the same buffer, and mounted on glass slides with Mowiol (Aldrich Chemical Co., Milwaukee, Wis.). Samples were studied under a Zeiss Axiophot fluorescence microscope, and images were collected with a MicroMax digital camera system.
EM of cell cultures. (i) Thin-section analysis. Ultrastructural analysis of control and Bunyamwera virus-infected cells was done by conventional embedding or by freeze-substitution and embedding in epoxy-resin EML-812, using procedures previously described in detail (29, 31, 33). Conventional embedding in EML-812 (Taab Laboratories, Adermaston, Berkshire, United Kingdom) was done after chemical fixation in situ in a mixture of 2% glutaraldehyde and 1% tannic acid in HEPES buffer, followed by a short dehydration series at 4°C. Freeze-substitution was performed in a dedicated automated freeze substitution unit (AFS; Leica-Reichert-Jung, Vienna, Austria) on cells previously frozen in liquid propane and subsequently substituted at -90°C in pure acetone containing 1% osmium tetroxide. Ultrathin sections approximately uniform in width (30 to 40 nm) were either stained with uranyl acetate and lead citrate or subjected to detection of specific components.
(ii) Ultrastructural labeling of specific components. Bunyamwera virus proteins were detected on thin sections of freeze-substituted samples or on frozen-hydrated cryosections. Immunolabeling on conventional thin sections was performed by well-established procedures, previously described in detail (28, 31). For ultrastructural detection of RNA, a complex of RNase and 10-nm-diameter colloidal gold (EY Laboratories, San Diego, Calif.) was used as described previously (29). Thin-sections from freeze-substituted samples were collected on gold electron microscopy (EM) grids covered with Formvar and carbon and incubated for 30 min at room temperature with the gold conjugate diluted 1:40 in PBS. After being washed with PBS and distilled water, samples were stained with uranyl acetate and lead citrate. To unmask viral RNA molecules, some sections were subjected to the following treatment before incubation with RNase-gold: 15-min incubation at 37°C with proteinase K (1 µg/ml in Tris-EDTA), washing with PBS, 10-min fixation with 4% paraformaldehyde in PBS, washing again with PBS, and incubation for 10 min with 0.2 M NH4Cl. As a cytochemical control, some sections were preincubated for 30 min at 37°C with a solution of nonconjugated RNase (20 µg/ml) before being treated with the RNase-gold conjugate.
For labeling on cryosections, cell monolayers were chemically fixed at 4°C with a mixture of 4% paraformaldehyde and 0.1% glutaraldehyde in PBS. After being washed with PBS containing 50 mM glycine, the cells were embedded in gelatin, fixed again with 4% paraformaldehyde in PBS, infused gradually from 0.6 to 2.3 M sucrose in PBS at 4°C, frozen in liquid propane, and stored in liquid nitrogen. Thin-sections were prepared in an ultracryomicrotome (Leica EM FCS, Vienna, Austria) operating at -120°C. Immunogold labeling was later performed as described previously (37).
(iii) Freeze-fracture. Conventional freeze-fracture was performed as described previously (30, 31). Cell monolayers were chemically fixed in situ, cryoprotected with glycerol, frozen in liquid ethane, and transferred to the BAF 060 freeze-etching unit (Bal-Tec). Fracture was done at -150°C. Metal replicas were done immediately after fracturing by evaporating 2 nm of platinum with an electron gun at an angle of 45° and 20 nm of carbon with an electron gun at an angle of 90°. Replicas were floated in commercial bleach and incubated overnight. After extensive washing in water, the replicas were picked up in Formvar-coated EM grids and studied by EM.
(iv) Processing of viral particles from culture supernatants. Virions released by infected cultures were processed by negative staining, particle counting, or freeze-etching, before being studied by TEM. Negative staining with uranyl acetate and sodium phosphotungstate was performed after adsorbing the viral particles on EM grids made hydrophilic by glow discharge, by using standard procedures (28). The number of particles in cell supernatants was calculated after making a series of dilutions of the virus stocks and a standard solution of latex spheres. This standard, provided by Ted Pella, Inc. (Redding, Calif.), contained latex spheres of 93 nm in diameter and known concentration (2.415 x 1011 particles/ml). After negative staining, samples were studied by TEM and counting was done in the samples containing similar numbers of viral particles and latex spheres.
(v) Imaging and quantitative analysis. Collection of images, measurements, and quantifications were done in a JEOL 1200-EX II electron microscope operating at 100 kV. Electron micrographs were scanned using an Epson Perfection 2450 PHOTO scanner and Picture Publisher 8 software.
|
|
|---|
![]() View larger version (162K): [in a new window] |
FIG. 1. Progression of infection by Bunyamwera virus in BHK-21 cells. (A and B) Immunofluorescence detection of G1 protein at 5 h p.i. (A) and 10 h p.i. (B). (C) EM of the Golgi area in a BHK-21 cell at 10 h p.i. (conventional processing). At least four potential types of virus-related structures are distinguished: budding arcs (white arrowheads), annular spherical particles (black arrowheads), dense spherical particles (arrows), and elongated tube-like structures (asterisk). (D) Typical view of perinuclear Golgi membranes with tubular structures: arrows point to longitudinal sections of tubes, while the double white arrowhead points to cross-sectioned tubes. The single white arrowhead points to a budding arc, while a viral particle is marked with v. (E) Some tubes are seen inside Golgi sacculi (arrow). (F) The three types of round viral assemblies detected in Golgi stacks are shown together: the double white arrowhead points to the cross-section of a tube, the black arrowhead points to an IAV, and the arrow points to an IDV. (G to L) Freeze-substituted infected cells showing the structure and dimensions of the different viral assemblies after high-preservation processing methods. (G) Three annular, less dense particles (IDVs) are seen on the right, while a dense virus (IDV) is seen on the left. (H) EDVs contain a dense surface layer of spikes (arrow) absent in IDVs. The white arrowhead in panel H points to a surface section of an extracellular particle, where the arrangement of surface spikes can be seen. (I) tube; (J) IAV; (K) IDV; (L) EDV. Bars: 200 nm (C and D); 100 nm (E to L).
|
![]() View larger version (129K): [in a new window] |
FIG.2. Cytochemical characterization and quantification of the different virus-related assemblies in BHK-21 cells (A to H). An anti-Bunyamwera virus antiserum (A to D) and a complex of RNase and colloidal gold (E to H) were used. A cryosection is shown in panel D, while sections of freeze-substituted samples are shown in panels A to C and E to J. The specificity of RNase-gold labeling was assessed with positive (I) and negative (J) controls. (K) Distribution of the different viral assemblies in BHK-21 cells at early times p.i. For quantification, 25 infected cells were studied at 6, 7, 8, 10, 24, and 48 h p.i. On the other hand, 50 cells were studied at 5 h p.i. The total number of structures is indicated on the y axis for each time p.i. A total of 1,194 viral structures were included in the quantification. Bars representing the number of viral tubes are marked with asterisks. (L) These tubes were frequently observed as structures with both ends closed (arrows), interrupted membranes (black arrowheads), and different arrangements within the Golgi stack (arrows and double white arrowhead). (M) Tube (arrow) associated to the Golgi stack (G), as visualized by freeze-fracture. (N) Golgi-associated tubes and mitochondria were frequently connected (arrow). G, Golgi complex; mi: mitochondria. Bars, 100 nm.
|
![]() View larger version (110K): [in a new window] |
FIG.3. MGM treatment of BHK-21 cells. (A and B) Immunofluorescence localization of the trans side of the Golgi complex (with the lectin WGA) in noninfected untreated (A), and MGM-treated (B) BHK-21 cells. (C) Reversal of the drug's effects. (D to F) WGA labeling shows similar MGM effects on Bunyamwera virus-infected BHK-21 cells. (D) Cells at 10 h p.i. (E) Cell at 10 h p.i. but with the last 6 hours in the presence of MGM; (F) Cell subjected to the same treatment as in panel E but incubated for 2 h after removing the drug. (G) Ultrastructure of BHK-21 cells after MGM treatment. Asterisks mark the swollen trans-Golgi subcompartments, some of them still attached to the Golgi sacculi. (H and I) Localization of the cis side of the Golgi complex (with an anti-giantin antiserum) in noninfected untreated (H) and MGM-treated (I) cells. (J and K) Localization of Bunyamwera virus G1 protein during MGM treatment in infected cells (J) and after reversal of the drug's effects (K). (L) Accumulation of tubes (double white arrowheads) and annular viruses (black arrowheads) in Golgi membranes of MGM-treated cells. (M) Accumulation of dense intracellular viruses (arrows) in Golgi membranes after reversal of the effects of MGM in the absence of cycloheximide. (N) After reversal of the effects of MGM in the presence of cycloheximide, the number of intracellular viruses decreases and the edvs (v) are more abundant. (O) Quantification of the different viral assemblies in untreated infected cells and in infected cells subjected to the different treatments: "untreated" cells are BHK-21 cultures at 10 h p.i. without MGM treatment; "MGM" cells at 4 h p.i. were treated with the drug until 10 h p.i.; "Rev-cy" corresponds to cells treated with the drug as in "MGM" and incubated for a further 2 h after removing the drug from the cultures (total, 12 h p.i.); finally, "Rev+cy" corresponds to cells also subjected to 2 h of reversion of the effects of MGM but in the presence of 100 µg of cycloheximide per ml. A total of 1,254 viral structures were included in the quantification. N, nucleus. Bars, 0.5 µm (G and N); 100 nm (L and M).
|
![]() View larger version (143K): [in a new window] |
FIG. 4. Second maturation step for Bunyamwera virus in BHK-21 cells. (A to D) Labeling with anti-Bunyamwera virus antiserum on cryosections of infected cells. (A) Viral particles inside the Golgi complex (G) are marked with arrows (moderate labeling), while viruses in the post-Golgi area are marked with arrowheads (weak to moderate labeling). (B) Viral particles inside secretory vesicles (sv) reaching the plasma membrane exhibiting weak labeling. They are near an area where viral particles are already exiting the cell and are strongly labeled (arrows). (C and D) Extracellular viral particles attached to the cell surface, exhibiting strong labeling on their periphery. (E and F) Extracellular viral particles visualized after negative staining with uranyl acetate (E) and sodium phosphotungstate (F). The surface spikes are clearly distinguished in the latter. Bars, 100 nm.
|
![]() View larger version (96K): [in a new window] |
FIG. 5. Progression of Bunyamwera virus infection in Vero cells. (A and B) Immunofluorescence localization of Bunyamwera virus G1 protein at 5 h p.i. (A) and 12 h p.i. (B). (C to E) Immunofluorescence detection of Golgi with an anti-giantin antiserum in noninfected cells (C) and in infected cells at 3 h p.i. (D) and 6 h p.i. (E). (F to H) Detection of ERGIC with an anti-ERGIC-53 monoclonal antibody in noninfected cells (F) and in cells infected at 4 h p.i. (G) and 6 h p.i. (H). (I and J) Detection of the RER with an anti-protein disulfide isomerase (PDI) antiserum, both in noninfected cells (I) and in Bunyamwera virus-infected cells at 4 h p.i. (J). (K and L) Double-immunofluorescence localization of Bunyamwera virus G1 (K) and Golgi membranes (L) at 6 h p.i. (M and N) The organization of the microtubular network is shown in noninfected (M) and infected (N) cells at 5 h p.i., using an anti-tubulin antibody.
|
![]() View larger version (133K): [in a new window] |
FIG. 6. Ultrastructural analysis of Bunyamwera virus infection in Vero cells. (A) Control, noninfected Vero cell with the characteristic organization of Golgi (G), RER, and mitochondria (mi). (B and C) Ultrastructure of infected Vero cells at 8 h p.i. A fragmented Golgi stack is shown in panel B, while general fragmentation of endomembranes is marked with arrows in panel C. (D to H) Bunyamwera virus-relatedassemblies in Vero cells: tube in Golgi membranes showing connections with the Golgi stack (arrow) and areas open to the cytoplasm (arrowheads) (D); cross-sectioned tube attached to a mitochondrion (arrow) (E); iav in Golgi membranes (F); idv (G); and edv (H). Samples were processed by conventional processing in panels A to E, while freeze-substituted cells were used in panels F to H. (I) Quantification of the different viral assemblies found in Vero cells at different times p.i. Bars representing the amount of viral tubes are marked with asterisks. A total of 25 infected cells were studied at each time p.i., and 1,285 viral structures were included in the quantification. (J) Growth curves and plaque morphologies of Bunyamwera virus in BHK-21 and Vero cells. Bars, 0.5 µm (A); 1 µm (C); and 100 nm (B and D to H).
|
|
|
|---|
Assembly of Bunyamwera virus in BHK-21 cells. As summarized in Fig. 7, a large structure is formed in the perinuclear area of infected cells. Golgi stacks in contact with mitochondria build a "viral factory" for Bunyamwera virus. Viral assembly and structural maturation take place in these complexes. Immature viruses transform into mature particles anywhere inside the stack while in the presence of a functional trans-Golgi, as demonstrated by using the trans-Golgi-disrupting drug MGM. Early in infection, tubes are seen in the Golgi region, where they often connect with surrounding mitochondria.
![]() View larger version (46K): [in a new window] |
FIG. 7. Model for Bunyamwera virus assembly pathway showing the formation of the viral factory and the main maturation steps. Golgi stacks and mitochondria form a large complex, with viral tubes connecting them. Budding profiles, viral tubes, immature annular viruses, and mature dense viruses have been introduced in different locations within the Golgi stack, according to our experimental data.
|
The virus that exits the Golgi is not the same as that found in the extracellular environment: a second structural transformation takes place at the moment of secretion from the cell. This second maturation results in a prominent layer of round spikes. Although this second maturation step becomes evident as virions are released from cells, technical limitations meant that we cannot rule out the possibility that these changes occur intracelullarly. To characterize this step more adequately, cryomicroscopy and freeze-etching studies of purified intracellular viruses are now in progress.
Bunyamwera virus tubes. Our study has detected another new viral structure: tubular elements built in the Golgi region, which are surrounded by a membrane frequently connected with mitochondria. Although some of these tubes are inside Golgi sacculi, they are frequently located on the periphery of the Golgi stacks. Their membrane could then be derived from the endoplasmic reticulum as well. This could explain the potential continuities with mitochondria. Their role remains to be defined, but the fact that they are built early in infection, coincident with the EM detection of the first viral particles, and in rather fixed amounts (one to three per stack), suggests that they are not aberrant, late assemblies and points to a role in infection. Several options seem possible: they could be unusual replication complexes, even more unusual assembly intermediates, or structures for communication between the organelles building the "viral factory." There are no previous descriptions for morphogenetic intermediates or replication complexes with such a structure. However, we think that this latter option is possible, taking into account the observation that the number of tubes increases at the beginning of assembly and decreases when the release of viral particles reaches the highest levels. It is known that enveloped viruses that assemble intracellularly form their replication complexes in vesicles derived from intracellular membranes (18, 21, 35) while assembly can take place in a different location. If replication actually takes place in Golgi-associated viral tubes, the replicated genomes need to gain access to the cytoplasmic side of Golgi membranes for assembly. This could be taking place through open areas found in the tubes, where membranes are interrupted and are in communication with the cytoplasm. In situ colocalization of RNA synthesis and the viral polymerase will help us to understand if the viral tubes are indeed replication complexes or could play some other role during infection.
Another peculiar feature of the viral tubes is that they frequently connect with the external membrane of mitochondria recruited on the perinuclear area of the infected cell. Direct mitochondrion-Golgi contacts are also detected. Mitochondria are known to establish very close contacts with membranes belonging to the endoplasmic reticulum, through a mechanism regulated by calcium (38). However, the Golgi-mitochondrion associations we detected in both BHK-21 and Vero cells were induced by bunyavirus infection. Clustering of mitochondria on the perinuclear region of the cell has been detected in cells infected with rubella virus (4). In these cells, mitochondria are recruited around viral replication sites in modified endosomes and lysosomes, and this association has been proposed to provide the energy required for virus replication.
Assembly of Bunyamwera virus in Vero cells. Bunyamwera virus-infected Vero cells do not exhibit the typical pattern of a Golgi-associated virus as shown in infected BHK-21 cells. Rather, viral antigen is distributed as small dots all over the cytoplasm, and this is observed from the beginning of infection. This could indicate a different assembly pathway in Vero cells, since cell specific factors can be determinants of the morphogenesis and morphology of some viruses (32). However, visualization of the Golgi complex in infected Vero cells revealed a general fragmentation and dispersion of this compartment before accumulation of viral glycoproteins could be detected. Although the ERGIC and RER were also altered, no general cell lysis was observed. We first thought that disruption of cytoskeletal components could be involved in the early fragmentation of endomembranes in Vero cells. However, only microtubules showed some bundling, which was detected 2 h after fragmentation of membranes had been completed. Fragmentation and dispersal of the Golgi complex has also been observed during infection with herpes simplex virus in different cell types (7). This effect, mediated at least partly by fragmentation of microtubules, has been described as a late event caused by the huge influx of viral glycoproteins contained in virions and membranes flowing through the exocytic pathway. In bunyavirus-infected Vero cells, however, the effect is observed before the detection of viral glycoproteins or assembly of new viruses.
In spite of the significant structural alterations, in Vero cells the bunyavirus assembles in association with the remnants of Golgi stacks, where the first structural maturation also takes place. The same viral polymorphism (Golgi-associated tubes, iavs, idvs, and compact extracellular virions) was also observed in this cell type. Golgi-mitochondrion connections, sometimes mediated by viral tubes, were also seen. The early general fragmentation of endomembranes induced by the virus raises important questions, such as how assembly in the Golgi starts and how new viral particles are transported from the Golgi to the plasma membrane. Unconventional intracellular transport events could be involved.
In summary, a functional, although not necessarily structurally intact, Golgi complex is necessary for bunyavirus maturation in BHK-21 and Vero cells. Our future studies will focus on the identification of Golgi factors involved in the structural transformation of immature viruses inside the stack, the characterization of the second maturation step during transport of viruses from the Golgi to the extracellular environment, and the analysis of the potential function of viral tubes. These studies are now in progress.
I.J.S. and R.R.N. are recipients of fellowships for postgraduate students from the Gobierno Vasco and from the Ministerio de Ciencia y Tecnología of Spain, respectively. This work has been supported by grant BMC2000-0555 from the Ministerio de Ciencia y Tecnología (to C.R.), grant PB96-0818 from the Comisión Interministerial de Ciencia y Tecnología of Spain (to J.L.C.), and Wellcome Trust grant 048387 (to R.M.E.).
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»